Peroxisome Proliferator-Activated Receptor Targets for the Treatment of Metabolic Diseases

Coll, T., Barroso, E., Guardia, D. Á., Serrano, L., Salvadó, L., Merlos, M., Palomer, X., & Carrera, M. V. (2010). The Role of Peroxisome Proliferator-Activated Receptor β/δ on the Inflammatory Basis of Metabolic Disease. PPAR Research, 2010(), 228-238. https://doi.org/10.1155/2010/368467
Gregoire, F. M. (2008). Peroxisome Proliferator-Activated Receptor δ: A Target with a Broad Therapeutic Potential for Drug Discovery. PPAR Research, 2008(), 991-992-096. https://doi.org/10.1155/2008/736362
Cho, M. C., Lee, K., Paik, S. G., & Yoon, D. Y. (2008). Peroxisome Proliferators-Activated Receptor (PPAR) Modulators and Metabolic Disorders. PPAR Research, 2008(), 917-930-089. https://doi.org/10.1155/2008/679137
Vitale, S. G., Laganà, A. S., Nigro, A., Rosa, V. L. L., Rossetti, P., Rapisarda, A. M. C., Vignera, S. L., Condorelli, R. A., Corrado, F., Buscema, M., & D'Annaa, R. (2016). Peroxisome Proliferator-Activated Receptor Modulation during Metabolic Diseases and Cancers: Master and Minions. PPAR Research, 2016(), 222-230. https://doi.org/10.1155/2016/6517313
Rakhshandehroo, M., Knoch, B., Müller, M., & Kersten, S. (2010). Peroxisome Proliferator-Activated Receptor Alpha Target Genes. PPAR Research, 2010(), 417-436. https://doi.org/10.1155/2010/612089